Navigation Links
Par Pharmaceutical's Karen O'Connor Receives 2013 Cardinal Health Supply Chain Excellence Award
Date:10/24/2013

WOODCLIFF LAKE, N.J., Oct. 24, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. is proud to announce that Karen O'Connor, vice president, national accounts, has received the generic pharmaceutical manufacturer 2013 Cardinal Health Supply Chain Excellence Award.  The award was presented today at Cardinal's annual Business Partners Conference in Columbus, Ohio. 

The Cardinal Health Supply Chain Excellence Award recipient is judged across a variety of metrics specifically targeted at the importance of Cardinal's generic pharmaceutical manufacturer partners.  These metrics recognize actions taken by generic suppliers to enhance service levels and create efficiencies in the supply chain, including execution on new product launches. 

"It is especially gratifying to receive an award from a highly-valued strategic partner," said Renee Kenney, senior vice president generic sales for Par Pharmaceutical.  "Both Karen and Par are honored to be recognized by Cardinal Health for our unwavering commitment to customer service.  Our efforts underscore the importance of this partnership to Par and we are proud of the trust and confidence that Cardinal has placed in us." 

Ms. O'Connor has been responsible for managing the company's relationship with Cardinal Health since joining Par in 2007.  

About Par Pharmaceutical Companies, Inc.  
Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals.  For press release and other company information, visit www.parpharm.com

 


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum
2. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
3. CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
4. Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013
5. Norwich Pharmaceuticals is now Norwich Pharma Services
6. Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan
7. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
8. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
9. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
10. Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
11. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... CAMBRIDGE, England , May 25, 2016 /PRNewswire/ ... genomics company employing the precision of circulating tumour ... oncology, today announces the appointment of Professor ... will provide medical leadership across the clinical development ... that Inivata,s products help deliver significant improvements in ...
(Date:5/24/2016)... 24, 2016 Cirujanos holandeses han ... a los médicos a compartir sus mejores prácticas por ... mundial. Profesionales médicos de Europa, África, Asia ... a la aplicación, que combina la transmisión en vivo ... seguro. Educación   "Imagine un médico ...
(Date:5/24/2016)... May 24, 2016  Diana Russell suffers from a ... from the inside out.  This disease has put her ... her children and grandchildren to leave her home.  Because ... family cannot haul the wheelchair.  So if there is ... and Diana is left to wait for the bus. ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... , ... After a year and a half of planning the Multiple Pathways of Recovery ... Pathways of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott ... together to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... This ... of a stroke, which we as a society can control and change. , As ... occurs nearly every 40 seconds within the United States. Plus, with an estimated 129,000 ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
Breaking Medicine News(10 mins):